Smoking remains to be the major preventable cause of early
mortality and morbidity. At least 70% of the smokers who quit
smoking don't succeed despite the use of the best nicotine
replacement treatment (NRT) with behavior treatment. Findings
that there is an increased prevalence of depression among
smokers and that smokers with depression, have greater
difficulty quitting than those without depression led to the
investigation of antidepressants as aids for smoking cessation.
The aim of this review is to explore the research literature for
treating nicotine dependence with antidepressants. Bupropion,
which seems to be effective in smoking cessation treatment,
reduces withdrawal symptoms and weight gain, which occurs
after quiting smoking, and throughout out the treatment. With
these properties, bupropion comes in view as a useful treatment
intervention in smoking cessation.